Charles River and Akron Bio have announced the integration of the latter’s CSS liquid cytokines into the former's Cell ...

CRISPR Therapeutics AG (NASDAQ:CRSP), a leading biotechnology company specializing in gene-based medicines with a market capitalization of $3.45 billion, stands at a critical juncture as it navigates ...

Beam Therapeutics Inc. (NASDAQ:BEAM), a biotechnology company at the forefront of precision genetic medicines with a market capitalization of $1.87 billion, is navigating a critical juncture in its ...

What's on the horizon for the life sciences industry? Robin Johnson, PharmD, Gene Therapy Submissions Lead, inSeption Group What unique challenges do gene therapy submissions face compared to ...

Joe DePinto, MBA, discussed the findings of the McKesson 2024 Cell and Gene Therapy Report, providing insight into the ...

Blood centres cannot make cell therapies more accessible on their own. For decades they have partnered with hospitals to ...

Microbial neutralization must constantly achieve a six-log reduction threshold of Geobacillus stearothermophilus and comply ...

Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. My personal style signifiers are jeans, a great sweater and my ring by Italian designer Monica Castiglioni.

The Netflix doc “Don’t Die: The Man Who Wants to Live Forever” tries to paint a full portrait of anti-aging obsessive Bryan Johnson—but mostly, he just comes off as creepy. Entertainment ...

It is challenging and time-consuming for businesses that are not familiar with the cell therapy manufacturing process to build a solid supply chain with the tools and processes required to satisfy ...

Pfizer gave Sangamo Therapeutics coal for Christmas, terminating a hemophilia A gene therapy pact to deprive the cash-strapped biotech of up to $220 million in milestones. Pfizer’s decision sent ...

“Our study shows that we can deliver genes to renal tubules and podocytes [highly specialized cells] in the kidney, the two important target cell types for gene therapy, and while there is a ...